本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

NovaBay Pharmaceuticals Inc

0.5899
+0.00881.51%
成交量:8,883.00
成交额:5,173.60
市值:343.10万
市盈率:-0.23
高:0.5900
开:0.5899
低:0.5777
收:0.5811
数据加载中...
2024/07/23

SEC问询函

Form CORRESP - Correspondence
2024/07/13

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/07/11

[补充]招股说明书

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2024/07/11

重要事件披露

Form 8-K - Current report
2024/07/10

[补充]招股说明书

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2024/07/10

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/06/26

SEC问询函

Form CORRESP - Correspondence
2024/06/21

招股说明书

Form S-1 - General form for registration of securities under the Securities Act of 1933
2024/06/21

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/06/20

招股说明书

Form S-1 - General form for registration of securities under the Securities Act of 1933
2024/06/14

重要事件披露

Form 8-K - Current report
2024/06/07

重要事件披露

Form 8-K - Current report
2024/05/31

重要事件披露

Form 8-K - Current report
2024/05/31

重要事件披露

Form 8-K/A - Current report: [Amend]
2024/05/29

重要事件披露

Form 8-K - Current report
2024/05/10

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/04/22

重要事件披露

Form 8-K - Current report
2024/04/19

重要事件披露

Form 8-K - Current report
2024/03/29

[修订]年度报告

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
2024/03/26

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]